Companies To Watch

  1. Companies To Watch: ViewPoint Therapeutics 10/1/2016

    Dr. Leah Makley, president and CSO, founded ViewPoint based on five years of research she conducted in the lab of cofounder Dr. Jason Gestwicki, where all work is dedicated to protein misfolding, primarily in neurodegenerative diseases such as Alzheimer’s.

  2. Companies To Watch: Quark Pharmaceuticals 9/1/2016

    Having passed through much of the proof-of-concept gauntlet, the company and its products’ next big test will come in its Phase 3 trials, where the concept meets uncertainty at the macro scale.

  3. Companies To Watch: Enteris BioPharma 8/1/2016

    “When you’re working for other companies, there are two disadvantages — one, you don’t have full control of your destiny; two, the work tends to come in peaks and valleys.”

  4. Companies To Watch: Tunitas Therapeutics 7/1/2016

    Tackling novel treatment and prevention of the most serious allergies with new science and seasoned business talent.

  5. Companies To Watch: Addex Therapeutics 5/1/2016

    Targeting Parkinson’s dyskinesia and other rare CNS disorders with a novel receptor-binding approach.

  6. Companies To Watch: Osel 4/1/2016

    Live biotherapeutics to restore microbiomes — in midstage development for vaginal and urinary conditions — with a special focus on women’s health

  7. Companies To Watch: Egalet 3/1/2016

    Developing Safer Opioids In A Market Under Siege

  8. Companies To Watch Roundup 2/1/2016

    An Update On All The Companies We Profiled In 2015

  9. Companies To Watch: Symic Biomedical 2/1/2016

    Needed treatments in vascular injury, osteoarthritis, and maybe more, cleverly targeting the dynamic extracellular matrix.

  10. Companies To Watch: Catalyst Pharmaceuticals 1/1/2016

    Reemerging with a licensed drug for a rare neuromuscular disease — and treading carefully to set its price